Provided by Mori Hamada & Matsumoto
MHM was one of the first Japan-based law firms to establish a practice group dedicated to the life sciences, including health care, pharmaceuticals and medical sciences, and is now without doubt a market leader in this area. Our group practitioners comprise mostly of young and dynamic partners and associates who are attuned to emerging technologies. Its life sciences practice encompasses a wide range of legal matters, from regulatory issues to intellectual property to crisis management to mergers and acquisitions to financing to corporate restructurings, among others. Our lawyers regularly deal with the manufacture, importation and distribution of medical and pharmaceutical products and equipment, governmental approvals, strategic alliances, investments in bio-ventures, and specific regulatory and corporate governance issues affecting medical institutions. Consequently, we are regularly chosen by a wide range of pharmaceutical companies, medical device companies, and biotech start-ups, both domestic and foreign, to advise them on a wide range of legal issues related to their operations. Our experience has created a solid group of legal practitioners who are well-versed not only in the complex and constantly evolving laws and regulations affecting this important and expanding industry but in the specific, practical characteristics and needs of the industry as well.
Provided by Chambers
Mori Hamada & Matsumoto combines a strong corporate offering with notable expertise in healthcare law. The firm assists clients with pharmaceutical product and medical device licensing and development, as well as related patent protection, enforcement and litigation mandates. The team is regularly enlisted by leading Japanese and international clients on pharmaceutical and healthcare-related M&A transactions.
Provided by Mori Hamada & Matsumoto
Mori Hamada & Matsumoto advised Sawai Pharmaceutical with respect to the crisis management of a violation of the Pharmaceuticals and Medical Devices Act.
Provided by Chambers
The team were very knowledgeable about the pharmaceutical industry and answered my questions with a deep understanding of their field of expertise.
Mori Hamada & Matsumoto has a large number of professionals well versed in various legal fields, and they were able to collaborate effectively.
The team were very knowledgeable about the pharmaceutical industry and answered my questions with a deep understanding of their field of expertise.
Mori Hamada & Matsumoto has a large number of professionals well versed in various legal fields, and they were able to collaborate effectively.
Provided by Chambers
Yo Uraoka is well placed to handle life science transactions as well as regulatory and litigation work in the sector.
In addition to providing accurate advice on matters specific to life sciences companies, he offers precise guidance on due diligence and M&A. Moreover, his accuracy is exceptionally high.
Yo Uraoka has a wide range of knowledge and connections, so he is the first person I go to when I have any issues.
Takamasa Horio is an up-and-coming lawyer assisting pharmaceutical and medical device companies with regulatory matters. Clients benefit from his experience working as part of government bodies in the life sciences space.
He is very knowledgeable and experienced, and he puts himself in the client's shoes.
Takamasa Horio is a professional with strengths in knowledge and connections related to healthcare.
Provided by Mori Hamada & Matsumoto
Head of Department
Head of Department
Yasutaka (Head of Dep.) Tokuda
Head of Department
Provided by Mori Hamada & Matsumoto
Astellas Pharma Inc.
AstraZeneca K.K.
CANON MEDICAL SYSTEMS CORPORATION
Chugai Pharmaceutical Co., Ltd. (Roche Group)
DAIICHI SANKYO COMPANY, LIMITED
GSK plc.
Hitachi, Ltd.
ITOCHU Corporation
Johnson & Johnson Services, Inc.
Mitsubishi Tanabe Pharma Corporation
NIPRO CORPORATION
Nippon Shinyaku Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
SanBio Co,Ltd.
Sawai Pharmaceutical Co., Ltd.
Shimadzu Corporation